Judicial Stress from the Perspective of the Courtroom Artist by Channing Reeves

by Susan Eustis

Judicial Stress from the Perspective of the Courtroom Artist by Channing Reeves is highly recommended. It documents the stress judges feel in a visually gripping manner. The drawings are compelling and incisive, reaching into your very soul to describe the deleterious effects of stress. Though the book purports to describe the situation of stress for the judges, it has a universal appeal, describing the quandary of executives everywhere caught by too much work and too little time to do, too little support staff.

Posted in Uncategorized | Tagged , | Leave a comment

Martha Rose Reeves: When You See a Red Geranium and It Brightens Up Your Day

by Susan Eustis

No one ever leans on the red geranium to do anything important, no one ever cares about the other person quite as much as they care about themselves. So it goes, so is the world. The ensuing poetry is a compelling read, there is not any thought of putting down the book book until it is entirely finished and then you want to go back and back to read the different, compelling poems again, literature really.

When you see a Red Geranium and It Brightens Up Your Day is a wonderful book, it truly does as the title promises it brightens up the day.

Posted in Uncategorized | Tagged | Leave a comment

Martha Reeves Poetry is Wonderful: Rose Garland Mitten China and Teatime at the Drake

by Susan Eustis

This review is from: Rose Garland Mitten China and Teatime at the Drake (Kindle Edition) has a five star rating. The poetry is wonderful. In this book the poetry is exquisite, the people come alive, Martha’s indomitable mother, the sisters, the school. The tea time is described as it must have been, proper and compelling. The school, the pictures, the smiles, the bicycles are all a part of the poetry as it carries us into the world of Martha.

Posted in Uncategorized | Tagged | Leave a comment

Tele-Care Medical Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019

LEXINGTON, Massachusetts (March 28, 2013) – WinterGreen Research announces that it has a new study on Tele-care equipment Monitoring Market Shares and Forecasts, Worldwide, 2013-2019. The 2013 study has 387 pages, 106 tables and figures. Tele-care improves treatment of chronic disease, reduces cost of care delivery, lets baby boomers age gracefully in their homes, and supports expert delivery of health care to every person in the world. Tele care is evolving more sophisticated ways of monitoring vital signs in the home, thus protecting people in a familiar, comfortable environment. The improvements in care delivery relate to leveraging large information sources that permit understanding what care works for what conditions.

Tele-care systems server markets are anticipated to grow because they represent a way to steer patients with a particular clinician to those most expert in treating that particular condition. Tele-care is not yet to the point where it is able to be used effectively to implement changes that represent significant improvements in overall healthcare delivery, they are largely confined to being used in the treatment of chronic conditions.

The aim of tele-care systems that will grow markets significantly is if the tele-care is used to prevent the onset of chronic conditions of CHF and diabetes through interventional medicine, wellness programs, and simply intelligent nutrition and exercise programs implementation. Is this the task of the hospitals? Or, are well ness programs meant to be implemented elsewhere? In any case, tele-care represents the delivery mechanism for the programs.

Statins have a warning label that indicates that patients who take these drugs risk mental deterioration and diabetes. Is this what we want for our people? Or are there wellness programs that provide alternatives. These are issues confronting hospitals, physicians, clinicians, big pharma, and patients everywhere. We are all patients; the task is to figure out good tele-care systems that work to implement wellness programs before the onset of chronic conditions.

Under this scenario, the local physician and specialist becomes the expert in ordering the correct diagnostic tests, not just any test they can think of, but a proper test that is recommended by the expert systems and by the expert clinician. In this manner the out of control testing costs in the US can be controlled. There will need to be some law changes, there will need to be some adoption of protections for the expert doctors, but when decisions are backed by standards of care instantiated as tele health servers we begin to have a rational, very effective health care delivery system.

Use of tele-care systems in the treatment of chronic conditions is important. 90% of the cost of care delivery is tied up in the treatment of chronic conditions. A large percentage of the tele-care servers was sold in the U.S., where the VA system did home monitoring of 92,000 patients in 2012. Tele-care equipment shipments are anticipated to grow rapidly worldwide as efficiencies of scale are realized for monitoring and treating people with chronic conditions in a more standardized manner that addresses the particular combinations and clusters of conditions any one patient presents.

Tele-care systems rely on monitors with integrated connectivity. Systems use monitoring hubs with integrated cellular capability and carts that permit remote diagnosis for places where there is a shortage of good doctors and where people want second opinions from a trusted expert. A physician that sees hundreds of patients a week with a certain condition is more apt to render an accurate diagnosis and to provide effective treatment than a physician that only sees that condition once a year.

The only way to connect patients with a particular condition with a clinician expert in treating that condition is through telemedicine. Everyone knows that a surgeon who operates within a particular specialty every day is more expert than one who operates only once a year. The same is true across the board for all specialties.

Systems like the Bosch health management programs with evidence-based guidelines are great in this context. These evidence based systems can be used to keep physicians and clinicians focused on the most significant part of the condition being treated.

IBM Watson is similarly great in the context of connecting expert clinicians with patients presenting a certain combination of symptoms. This type of care delivery represents significant change, but it is change for the better, it is lower cost care delivery with higher quality of care. Watson or competing computing systems have the potential to be incredibly useful in this context. Because Watson and other cognitive computing systems can recognize clusters of symptoms in a particular patient, these types of systems are potentially useful in guiding patients to the care delivery clinician that is most likely to be able to recognize the best treatment and to provide the recommendation ot other clinicians as to what will be the highest level of effective care for the least cost.

The aim of tele-care is to improve patient compliance with standards of care known to support improved outcomes for patients with chronic conditions. Tele-care is one way to improve patient compliance, but there are other ways to achieve that as well.

Tele-care increases patient compliance. The aim is to improve the delivery of healthcare to clients by monitoring vital signs to detect changes in patient condition that may indicate the onset of a more serious event, much as nurses in the hospital monitor patient vital signs.

According to Susan Eustis, the principal author of the study, “The advantage of tele-care is that it increases patient compliance. It brings expert medicine into the home and attempts to present it in manner patients can hear. The aim is to improve the delivery of healthcare to clients by performing medical exams remotely and monitoring vital signs to detect changes in patient condition that may indicate the onset of a more serious event, much as nurses in the hospital monitor patient vital signs for the purpose of permitting sophisticated care delivery.”

Tele-care equipment units decrease the cost of care delivery while improving the quality of care and the quality of lifestyle available to patients. They have been widely adopted and extremely successful in use by the veterans administration in the US and by CMS Medicare and Medicaid. Use is anticipated to be extended to a wide variety of care delivery organizations based on this base of installed systems. Healthcare delivery is an increasing concern worldwide. Markets for the carts and associated servers segment of the market at $237.6 million in 2012 are anticipated to reach$3.3 billion by 2019.

Check out the WinterGreen Research Tele-Care Medical Equipment Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Quantum Dot and Quantum Dot Display (QLED): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2019

LEXINGTON, Massachusetts (March 26, 2013) – WinterGreen Research announces that it has published a new study Quantum Dot and Quantum Dot Display (QLED) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 221 pages, 80 tables and figures. Quantum dots will cascade into the marketplace. They offer lower cost, longer life, and brighter lighting.

According to Susan Eustis, “The commercialization of quantum dots using kilogram quantity mass production is a game-changer. High quality, high quantity and lowest price quantum dots increase product quality in every industry. The rate of change means speeded products cycles are evolving.”

Once manufacturers learn to integrate higher efficiency luminescent quantum dots into their products, each vendor will need to follow or dramatically lose market share. This level of change brought by quantum dot and quantum dot displays (QLED) represents a new paradigm that will create new industries, products and jobs in science and industry. The list of possible quantum dot applications is ever expanding. New applications are waiting for the availability of more evolved quantum dots.

Quantum Dot LED (QLED) commercial focus has remained on key optical applications: Optical component lasers are emerging as a significant market. LED backlighting for LCD displays, LED general lighting, and solar power quantum dots are beginning to reach the market. Vendors continue to evaluate other applications.

Quantum dots QDs are minute particles or nano-particles in the range of 2 nm to 10 nm diameter. Quantum dots are tiny bits of semiconductor crystals with optical properties that are determined by their material composition. Their size is small to the nanoparticle level. They are made through a synthesis process. QD Vision synthesizes these materials in solution, and formulates them into inks and films. Quantum Dot LEDs (QLED) enable performance and cost benefits.

The quantum dot cannot be seen with the naked eye, because it is an extremely tiny semiconductor nanocrystal. The nanocrystal is a particle having a particle size of less than 10 nanometers. QDs have great potential as light-emitting materials for next-generation displays with highly saturated colors because of high quantum efficiency, sharp spectral resolution, and easy wavelength tenability. Because QDs convert light to current, QDs have uses in other applications, including solar cells, photo detectors, and image sensors.

QLED displays are anticipated to be more efficient than LCDs and OLEDs. They are cheaper to make. Samsung estimates that they cost less than half of what it costs to make LCDs or OLED panels. QLED quantum dot display is better than OLED. It is brighter, cheaper, and saves more energy. Energy-savings is a strong feature. Its power consumption is 1/5 to 1/10 of the LCD’s Samsung offers now. Manufacturing costs of a display are less than half of OLED or LCD. It has a significantly longer life than the OLED.

QLED quantum dot display uses active matrix to control the opening and closing of the pixels of each color. Quantum dots have to use a thin film transistor. Emission from quantum dots is due to light or electrical stimulation. The quantum dots are able to produce different colors depending on the quantum shape and size used in the production of materials.

Dow Electronic Materials, a business unit of The Dow Chemical Company (NYSE: DOW) and Nanoco Group plc (AIM: NANO) have a global licensing agreement for Nanoco’s cadmium-free quantum dot technology. Under the terms of the agreement, Dow Electronic Materials will have exclusive worldwide rights for the sale, marketing and manufacture of Nanoco’s cadmium-free quantum dots for use in electronic displays.

Check out the WinterGreen Research Quantum Dot and Quantum Dot Display (QLED) Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Healthcare Decision Support and IBM Watson: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019

LEXINGTON, Massachusetts (March 19, 2013) – WinterGreen Research announces that it has published a new study Healthcare Decision Support and IBM Watson Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 271 pages, 87 tables and figures. Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, and new information systems that leverage natural language, and changing market conditions.

Healthcare decision support markets consist of traditional market participants led by McKesson and Watson from IBM. IBM Watson offers structured and unstructured data in combination. This represents a major breakthrough in what kind of decision support can be offered.

IBM Watson can provide a far more differentiated testing assessment. Watson knows what tests are relevant to further characterize a particular patient condition and what tests are not.

It is a great help to physicians to have an assistant that is able to have read the latest journal articles and is loaded with medical information to recommend what tests may be relevant in a particular situation. Wrong tests, tests that are not useful in a particular situation, account for 30% of the costs of healthcare delivery in the US. This is a lot. To have a new system available that addresses these issues is great.

IBM Watson is initiating a new era of cognitive computing that extends the tabulator and application program intensive enabling new market opportunities based on cognitive performance. Watson is so powerful and so new that the uses for it are not even defined yet. The tools and methods released by natural language computing systems are remarkable. They are very exciting.

Watson is comprised of a core engine. This engine is more powerful than anything that has been designed by humans before. To the credit of IBM, the first purpose that Watson has been put to is to improve healthcare delivery. To those analysts following Watson, there is tremendous promise in the offing.

IBM concentrates on building end to end systems that are able to adapt of market changes. While this may make the IBM product set seem overly heavy in the short run, in the long run, this is of enormous value to clients as proved by the company market leading position in innovation software.

This forecast below is predicated on the assumption that IBM makes available the Watson cognitive computing capability worldwide as a SaaS tool immediately, and people with smart phones learn that for five cents they can access solid medical opinions relating to particular symptoms. This does not turn the consumer into a healthcare provider, but it gives the consumer more power in dealing with the physician and the provider.

Just as the mother that took her child to the doctor this week in February 2013, and said, “I think it is an appendicitis” and the doctor said “No, it is influenza.”, after the appendix broke and threatened the life of the child, the mother was angry, the physician was apologetic. With Watson at her side, the mother would have had more credible authority with the doctor.

This scenario really happened to an esteemed marketing manager in Minnesota, USA this week in February 2013. Watson has a lot to offer the consumer, without making the consumer a doctor; it brings more information and authority to the patient – physician interaction.

So also, the physicians gain a valuable assistant at their side when they can access Watson for $60 per physician per month. This cost represents two cents per patient encounter, hardly a blip on the bill to the patient, but lends incredible value to the patient – physician interaction, bringing the latest research to bear on the physician diagnostic and therapeutic decision making process.

Watson can be loaded with the latest research results. No physician can track all the latest medical research; there are intense volumes of it. Any one physician can only hope to read a small portion of what is published in his or her own field. Watson knows it all. It is available to share what it knows at a small fee.

Healthcare decision support markets at $201.7 million in 2012 are anticipated to reach $239 billion by 2019 as consumers access apps and these apps generate micro-payments in increments of $.05 per query. Physician access is anticipated to be at a cost of $60 per month per physician, and every facility will have to give its physicians access to IBM Watson and cloud based healthcare decision support.

Personal, consumer queries are anticipated to account for 93% of the healthcare decision support revenue by 2019. Growth is a result of new cognitive computing technology availability. It is not enough to maintain a static position in a market, nimble competitors steal market share away if innovation is not pursued, this is increasingly true in the healthcare decision support markets. Innovation provides competitive advantage and protection of market position.

Check out the WinterGreen Research Healthcare Decision Support and IBM Watson Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Touch Panel Transparent Conductive Film: Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2019

LEXINGTON, Massachusetts (March 12, 2013) – WinterGreen Research announces that it has a new study on Transparent conductive film Market Shares and Forecasts, Worldwide, 2013-2018. The 2013 study has 227 pages, 88 tables and figures. Transparent conductive film improves electronic device usability. The ability to navigate using touch screens improves the usefulness of all electronic devices, paving the way of a spurt of innovation and new applications.

Transparent conductive film enables features of smart phones and electronics applications. Devices are evolving in response in part to the characteristics of the transparent conductive film that is used in the user interface. Products support collaboration. Solutions are competitive.

According to Susan Eustis, the principal author of the study, “The advantage of transparent conductive film is that a very thin layer of material as a coating on a surface can provide touch screen capability. Transparent conductive film supports electronic device usability. Factors that influence commercial success in the wireless device and services market relate to usability above all: The designs of the iPhone are genius designs because of the usability they bring. Development of an integrated hardware, software and service platform to support multiple wireless network standards is an essential aspect of market participation.”

The transparent conductive film markets are leveraging the expanding market opportunities related to mobile communication and media devices of smart phones and tablets among others. Transparent conductive film provides the base for device navigation by recognizing the presence of a finger as it moves across a screen. That navigation supports transmission of digital data into and out of the smart phone. The transparent conductive film markets are highly competitive. The competition is expected to intensify significantly as new technologies evolve.

Transparent conductive film principal competitive factors include price, product features, relative price/performance, product quality and reliability, design innovation, marketing and distribution capability, service and support, and corporate reputation. Indium tin oxide (ITO) has been the prevailing transparent conductive film used in touch screen applications. It requires an expensive and cumbersome sputtering deposition process. The price of indium is increasing rapidly and the film is rigid. There is demand for more flexible film in the market.

The Touch Panel Transparent Conductive Film TCF market is $956 million in 2012. Markets are anticipated to reach $4.8 billion by 2019. ITO is an entrenched technology for display manufacturing. Indium tin oxide (ITO) has been the transparent conductive film technology for touch screens. Newer technology will erode ITO and provide improved functionality as lower prices. Transparent conductive film supports electronic device usability.

Check out the WinterGreen Research Touch Panel Transparent Conductive Film Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

IBM Software Innovation: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019

LEXINGTON, Massachusetts (February 28, 2013) – WinterGreen Research announces that it has published a new study IBM Software Innovation Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 460 pages, 193 tables and figures. Worldwide markets are poised to achieve continuing growth as the enterprise seeks to develop new products in response to changing technology and changing market conditions.

IBM concentrates on building end to end systems that are able to adapt of market changes. While this may make the IBM product set seem overly heavy in the short run, in the long run, this is of enormous value to clients as proved by the company market leading position in innovation software.

The enterprise uses software innovation to transition to higher quality automated process, middleware to support smarter computing, and cloud computing in an era of smart phones. IBM is profiled as the leader in this software innovation initiative. The ability to federate and spread workloads securely between private and public clouds is “hybrid cloud computing.” One mission of software innovation is to lead customers on the journey to hybrid cloud computing.

Physical convergence with digital representations of the physical world is creating complexity. Communication between machine to machine has caused an inflection point for the need for a quickened pace for the management and design of assets with software representing a significant aspect of innovation implementation.

Software is able to support innovation in enterprise markets because software is so much easier to change than physical devices.

Some software is better than other software in supporting innovation. Simple software changes challenge the best of IT departments in many cases, just for software that is used to run the business. For software used to create entire new business initiatives, innovation software is needed. Innovation software is used to handle the complexity of supporting a current market offering while tailoring a new modality.

Software for innovation represents a category distinct from software for existing applications, middleware for existing applications, and upgrades to existing applications. Software for Innovation is that software that helps enterprises grow existing markets. For that reason, it is of interest to the line of business more than to the IT department.

Innovation is needed by an enterprise to gain competitive advantage and respond to change in markets. Software used to effect business change, to make innovation happen is fundamentally different from established applications software and the infrastructure that supports those applications. Software for Innovation is most often tuned to supporting any kind of analytics, to helping the line of business change the fundamental nature of the business as product cycles create new market opportunity that demands attention.

Good businesses learn to listen to clients. They interview customers and try to be responsive to customers. Customers, clients create fickle markets, demanding the newest and best in an inevitable manner. Enabling client capabilities as the foundation of business process speaks to the very heart of innovation. A lot of support is needed to enable enterprise IT departments to adapt existing systems to new challenges.

Software for innovation market driving forces relate to the need to adapt to market changes on an ongoing basis. People have difficulty with change; change is hard.

The worldwide enterprise software market at $295 billion showed broad growth in 2012. Growth was achieved as companies positioned to garner a presence in real time computing, adapt to the Internet as a channel, and embrace mobile devices as adjuncts to business process. Worldwide software revenue increased 8.9 percent in 2012. Software for innovation was a $73.4 billion sub-segment of the overall software market.

This is an entirely new category of software. As WinterGreen Research prepares to break out its software industry index worldwide, studies define the segments of the software industry more clearly. One of the things that jumps out of a close look at all the software industry segments worldwide is the software for innovation that is used primarily by the line of business to respond to the need for growth initiatives. This software goes beyond managing the existing business with implementation of automated process to giving the line of business tools that support growth initiatives.

Software for innovation markets at $73.4 billion in 2012 are anticipated to reach $196.4 billion by 2019. Growth is a result of enterprise need to innovate to grow. It is not enough to maintain a static position in a market, nimble competitors steal market share away if innovation is not pursued. Innovation provides competitive advantage and protection of market position.

Check out the WinterGreen Research IBM Software Innovation Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

LEXINGTON, Massachusetts (February 11, 2013) – WinterGreen Research announces that it has published a new study Intraocular Lens (IOL) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 293 pages, 67 tables and figures. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need Intraocular Lenses (IOL). All older people develop cataracts.

Cataracts are a clouding of the eye’s natural lens that impairs one’s ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting.

Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an ever-increasing baby boom aging population. There is a growing precision of cataract surgery. Safety of cataract surgical medical devices and lenses are primary market concerns. More advanced procedures are driving an increase in cataract surgery. Lower costs per surgery are driving an increase in cataract surgery.

Cataract surgical technology is evolving rapidly. Premium intraocular lenses (IOLs) introduced during the past decade and those still in the pipeline are raising patient’s post-cataract visual expectations. Laser-assisted cataract surgery technology is gaining traction with clinicians. Surgeons are getting trained in the techniques needed to perform surgeries these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the Intraocular Lens (IOL) market research study, “Superior image quality brings clinical improvement. Patients are thrilled when they can see so much more clearly.”

As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.

Ultrasonic phacoemulsification, the standard of care in cataract removal equipment for four decades, has been in great part responsible for the safety and effectiveness of modern cataract surgery. It is certain to remain the dominant lens removal technology in the near term. A technology still in its infancy, laser-assisted cataract surgery using femtosecond lasers and picosecond lasers, promises to raise the standard of precision and safety to new heights.

Numerous types, and styles of Intraocular Lenses (IOLs), varying in size, and attachment mechanisms. The femtosecond lasers may evolve capability to fix the cataract without implanting an IOL devices, creating a significant change in the market after the forecast period.

The eye care industry is highly competitive and subject to rapid technological change and evolving industry requirements and standards. Companies within this industry compete on technological leadership and innovation, quality and efficacy of their products, relationships with eye care professionals and healthcare providers, breadth and depth of product offering and pricing. The presence of these factors varies across regions.

In the United States, the leading market segment, an aging population, the affluence of the American “baby boomer” generation, and the ability of surgeons to bill for a premium refractive outcome will drive significant growth in this lens-based refractive surgery sector.

Intraocular Lens (IOL) markets are driven by the trend towards multi-distance vision capability, near middle, and far. The global market is expected to post a modest growth. The global market for Intraocular Lenses (IOL) total market value is expected to reach $3.8 billion by 2019.

The global intraocular lens cataract market is expanding with the aging of a more affluent middle class population. There were 19 million cataract surgeries in 2010 and 19.7 million in 2012. Cataracts account for 48% of world blindness. Cataracts are the leading cause of reversible blindness.

Check out the WinterGreen Research Intraocular Lens (IOL) Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | Leave a comment

Computed Tomography (CT): Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018

LEXINGTON, Massachusetts (February 7, 2013) – WinterGreen Research announces that it has published a new study Computed Tomography (CT) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 412 pages, 185 tables and figures. Worldwide markets are poised to achieve continuing growth as CT gains significant new imaging clarity.

CT imaging is useful for healthcare therapeutic decision-making. Infarctions caused by stroke and extensive bleeding are types of conditions imaged. Subarachnoid hemorrhage and a ruptured aneurysm are imaged. Seeing the conditions clearly makes a huge difference in choosing between different treatment options. CT is a primary diagnostic tool in oncology. It is used to detect cancer, for oncologic treatment follow-up and in assessing the lung diseases. In emergency care, CT has become the primary test for trauma, stroke or chest pain.

According to Susan Eustis, lead author of the study, “Superior image quality brings clinical improvement. Physicians are thrilled when they can see what is going on so much more clearly. Market leaders in the higher-slice segments have proven superior image quality. They have pressure to prove they can incorporate effective dose-reduction techniques while maintaining image quality. High end imaging modalities require advanced image management and archival systems. The diagnostic outcome of molecular imaging is made available to clinicians. Healthcare IT and molecular imaging exploit the advantage of systems. Effective distribution of images to clinicians is needed. Integration with electronic medical records is critical.”

This growth is driven in part by the growing popularity of independent diagnostic centers, which are increasing in number due to patient demand and the relatively low set-up cost compared to a full, multi-disciplinary hospital.

Other drivers of growth include the increasing demands from governments for high quality healthcare delivery that is supported with CT imaging. Significant advances in imaging technologies promise to improve wellness through earlier and more accurate detection of medical conditions.

Aging population and increase in the chronic disease, congestive heart failure and diabetes in the population are considered as the main drivers of the imaging market in the developed nations. Obesity and use of statins are primary drives of chronic diseases. Lack of exercise and lack of good nutrition are underlying causes of obesity. A rising fiscal deficit is expected to inhibit the growth of CT in the developed nations.

CT scans help physicians determine whether curative or palliative treatment is the best course of treatment. CT works for patients for esophageal cancer. The CT market is shaped by instruments capable of high scanning speed. High scanning speed reduces examination time and radiation exposure for patients. CT is useful for managing increasing rates of cardiovascular disease and cancer. In the face of a population explosion worldwide demand for healthcare has created a need for screening and early diagnosis of cardiovascular disease and cancer conditions.

CT imaging radiation dose continues to be an area of concern. The industry continues to try to reduce exposure while ensuring image quality. Recent studies have centered on the correct dose for children and the obese. Worldwide, research is going to improve the current technology of CT. Two topics are the focus of clinical research: reduced radiation, and evaluation of the hemodynamic significance of coronary stenosis.

Growth comes as more emphasis is put on early diagnosis and prevention of disease. Heart failure patients can benefit from better imaging.

Computed tomography scanner markets are driven by the trend towards multi-slice scanners, the global market for computed tomography scanners is expected to post a modest growth rate. The global market for CT scanners was valued at $3.7 billion in 2012. Total market value is expected to reach $6 billion by 2019.

Check out the WinterGreen Research Computed Tomography (CT) Study here.

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment